Clinical evaluation of human papillomavirus detection by careHPV™ test on physician-samples and self-samples using the indicating FTA Elute® card

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 17, 2014, Pages 7085-7090

  Wang, Shao Ming ^a   Hu, Shang Ying ^a   Chen, Feng ^a   Chen, Wen ^a   Zhao, Fang Hui ^a   Zhang, Yu Qing ^a   Ma, Xin Ming ^a   Qiao, You Lin ^a  

^a CANCER HOSPITAL   (China)

Author keywords

CareHPV test; Cervical cancer screening; Self sampling; Whatman indicating FTA elute card

Indexed keywords

VIRUS DNA;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHINA; DEVICES; EARLY DIAGNOSIS; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; SELF CARE; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHINA; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; SELF CARE; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84907274539     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.17.7085     Document Type: Article

References (17)

1. Arbyn M, Ronco G, Anttila A, et al (2012). Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine, 30, 88-99.
2. Gage JC, Ajenifuja KO, Wentzensen N, et al (2012). Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria. Int J Cancer, 131, 2903-9.
3. Gonzalez P, Cortes B, Quint W, et al (2012). Evaluation of the FTA carrier device for human papillomavirus testing in developing countries. J Clin Microbiol, 50, 3870-6.
4. Guan Y, Castle PE, Wang S, et al (2012). A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China. Sex Transm Infect, 88, 490-4.
5. Guan Y, Gravitt PE, Howard R, et al (2013). Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens. J Virol Methods, 189, 167-71.
6. Gustavsson I, Lindell M, Wilander E, et al (2009). Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV. J Clin Virol, 46, 112-6.
7. Gustavsson I, Sanner K, Lindell M, et al (2011). Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge. J Clin Virol, 51, 255-8.
8. IARC (2005). Cervix Cancer Screening IARC Handbooks of Cancer Prevention 10.
9. Kang LN, Jeronimo J, Qiao YL, et al (2014). Optimal positive cutoff points for careHPV testing of clinician-and self-collected specimens in primary cervical cancer screening: an analysis from rural China. J Clin Microbiol, 52, 1954-61.
10. Lenselink CH, de Bie RP, van Hamont D, et al (2009). Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening. J Clin Microbiol, 47, 2564-70.
11. Phongsavan K, Gustavsson I, Marions L, et al (2012). Detection of human papillomavirus among women in Laos: feasibility of using filter paper card and prevalence of high-risk types. Int J Gynecol Cancer, 22, 1398-406.
12. Qiao YL, Sellors JW, Eder PS, et al (2008). A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol, 9, 929-36.
13. Ronco G, Dillner J, Elfstrom KM, et al (2014). Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet, 383, 524-32.
14. Sankaranarayanan R, Esmy PO, Rajkumar R, et al (2007). Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet, 370, 398-406.
15. Yoshida T, Nishijima Y, Hando K, et al (2013). Primary study on providing a basic system for uterine cervical screening in a developing country: analysis of acceptability of self-sampling in Lao PDR. Asian Pac J Cancer Prev, 14, 3029-35.
16. Zhang SK, Ci PW, Velicer C, et al (2014). Comparison of HPV genotypes and viral load between different sites of genital tract: the significance for cervical cancer screening. Cancer Epidemiol, 38, 168-73.
17. Zhao FH, Lin MJ, Chen F, et al (2010). Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol, 11, 1160-71.